Para manejo de peso, opciones como naltrexona-bupropin, orlistat, fentermina-topiramato o fentermina (para uso a corto plazo) pueden considerarse, aunque generalmente con menor eficacia que los GLP-1
Instead of: Constant thoughts about food can make it hard to focus on anything else (NIH)
A recent review found that patients using GLP-1 medications may be at increased risk for 19: Low protein intake Reduced intake of key micronutrients like vitamin D, iron, and calcium Declines in vitamin B12 and thiamine (B1) over time In some cases, this may contribute to: Fatigue or low energy Loss of lean muscle mass Longer-term nutrient deficiencies, if not addressed This is not a reason to avoid these medications, but it does highlight the importance of dietary quality and intentional nutrition support from a qualified professional while using them
Such dietary shifts could plausibly promote type 2 diabetes risk through excess caloric load, central adiposity, and glycemic stress. The association presented in this research emerges in a context of increasing legalization for cannabis and cannabis products
GH and IGF-1 promote stronger bones
Gastrointestinal side effects may limit dose escalation for some individuals